Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

for
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
Location: Houston TX, Louisville KY, Fairfax VA
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07407933

Phase1, Phase2, Recruiting

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT01371630

Phase1, Phase2, Recruiting

How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients With Advanced Blood Cancers

for
Advanced Hematologic Malignancies
Location: Houston TX
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT07444268

Phase1, Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

for
Hematologic Malignancies
Location: Houston TX, Dallas TX, Birmingham AL, Newnan GA,
Sponsor: Sellas Life Sciences Group

Sex: All

Age: 12+

Code: NCT04588922

Phase1, Phase2, Recruiting

Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

for
Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation,
Location: Houston TX, Nashville TN, Spartanburg SC, Chicago IL,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT06501625

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia

for
Cytopenia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06285825

Phase2, Recruiting

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Houston TX, Atlanta GA, Sarasota FL, Denver CO,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05131022

Phase1, Recruiting

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

for
Macular Telangiectasia Type 2 (MacTel)
Location: Houston TX, Dallas TX, Atlanta GA, Knoxville TN,
Sponsor: Neurotech Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06971939

Recruiting

ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05010122

Phase1, Phase2, Recruiting

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

for
Advanced or Metastatic Solid Tumor, Liver Failure
Location: Houston TX, San Antonio TX, Baltimore MD, Newark DE
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT04617522

Phase1, Recruiting

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

for
HIV Infections
Location: Houston TX, Bellaire TX, Longview TX, Dallas TX,
Sponsor: ViiV Healthcare

Sex: All

Age: 18+

Code: NCT07202546

Phase2, Recruiting

Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study

for
Stem Cell
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06004063

Recruiting

A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)

for
Phase 1b, HC-7366, SHARK, Kidney Cancer
Location: Houston TX, Dallas TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07401875

Phase1, Recruiting

Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

for
Thyroid Carcinoma
Location: Houston TX, Sarasota FL
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07218315

Recruiting

Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

for
Medullary Thyroid Cancer (MTC), Cultural Adaptation
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07142005

Recruiting

Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function

for
Lu-177 PSMA
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 0+

Code: NCT07169825

Recruiting

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06085729

Phase1, Phase2, Recruiting

Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study

for
Urinary Tract Infection
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: Male

Age: 0

Code: NCT07508124

Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

for
Esophageal Squamous Cell Carcinoma,
Location: Houston TX, Austin TX, San Antonio TX, Fort Worth TX,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07503808

Phase1, Recruiting

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

for
Acute Promyelocytic Leukemia (APL),
Location: Houston TX, Birmingham AL, Nashville TN, Augusta GA,
Sponsor: Quetzal Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07504458

Phase3, Recruiting